Show Summary Details
Page of

Future treatments 

Future treatments
Chapter:
Future treatments
Author(s):

Uta Griesenbach

, Jane Davies

, and Eric Alton

DOI:
10.1093/med/9780199582709.003.0012
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 17 December 2017

Increased understanding of CF pathophysiology is leading to new therapies

Several gene therapy trials have established proof-of-principle for gene transfer in the airways, but a gene therapy-based treatment has not yet been developed

Small molecule drugs directed at class-specific CFTR mutations are showing promise in early phase trials

Drugs aimed at restoring hydration of the airway surface have been shown to improve mucociliary clearance

Increasing numbers of antibiotics are being formulated for both nebulization and inhalation.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.